The Journal of Practical Medicine >
Changes and role of CD74 and CXCL9 positive macrophage subsets in rejection of rat liver transplantation
Received date: 2023-06-16
Online published: 2024-01-08
Objective To explore the classification and changes of macrophage subsets in liver transplant rejection. Methods Rat liver transplantation model were established and divided into immune tolerance group (B-B), where the liver of BN rat donors was transplanted to BN rat recipients, and immune rejection group (L-B), in which the liver of Lewis rat donors was transplanted to BN rat recipients. Single-cell RNA sequencing and high-throughput RNA sequencing were used to distinguish the macrophage subsets of rat liver transplantation, and to find differential gene in rejection reactions. Immunohistochemistry was used to determine the changes and distribution of protein expression and cell subsets. Results CD68 positive macrophages were higher in the rejection group than that in the tolerance group (P < 0.05), and macrophages could be divided into 9 subsets. During the rejection reaction, the CXC chemokine ligand 9 (CXCL9) in the 8th subsets of macrophages was significantly increased, while the gene for white blood cell differentiation antigen 74 (CD74) in the 5th subsets was significantly increased (P < 0.05). CD74 ranked first in the differential gene synthesis of macrophages during rejection, followed by CXCL9. Compared with the tolerance group, a large number of CD74 positive macrophages were observed in the hepatic portal area of the rejection group, and the infiltration of CD74 positive macrophages in the hepatic sinuses was also significantly increased (P < 0.05), while a large number of CXCL9 positive macrophages were observed in the hepatic portal area and hepatic sinuses of the rejection group, especially in the portal area (P < 0.05), and CD14 positive cells were significantly increased (P < 0.05). Conclusions The CD74 positive macrophage subsets and CXCL9 positive macrophage subsets may be key subgroups in promoting liver transplant rejection, improving the mechanism of macrophage action in liver transplant rejection.
Sidong WEI , Kaige CHEN , Jixiang ZHANG , Juanjuan XUAN , Yaoquan WANG , Shun MIAO , Kaixin ZHAO , Weiwei WANG , Guoyong. CHEN . Changes and role of CD74 and CXCL9 positive macrophage subsets in rejection of rat liver transplantation[J]. The Journal of Practical Medicine, 2023 , 39(23) : 3027 -3033 . DOI: 10.3969/j.issn.1006-5725.2023.23.002
| 1 | 周结学, 刘东, 蒙善东, 等. 体外光化学疗法对大鼠肾移植抗排斥反应的研究[J]. 实用医学杂志, 2023, 39(8): 944-947. |
| 2 | MONTANO-LOZA A J, RODRíGUEZ-PERáLVAREZ M L, PAGEAUX G P, et al. Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation [J]. J Hepato, 2023, 78(6): 1199-1215. |
| 3 | FAHRNER R, DONDORF F, ARDELT M, et al. Role of NK, NKT cells and macrophages in liver transplantation[J]. World J Gastroenterol, 2016, 22(27): 6135-6144. |
| 4 | JIA J, TIAN X, JIANG J, et al. Structural shifts in the intestinal microbiota of rats treated with cyclosporine A after orthotropic liver transplantation [J]. Front Med, 2019, 13(4): 451-460. |
| 5 | MENG Q, WU W, ZHANG W, et al. IL-18BP improves early graft function and survival in lewis-brown norway rat orthotopic liver transplantation model[J]. Biomolecules, 2022, 12(12): 1801. |
| 6 | MO J, CHEN Y, CHENG Y, et al. miR-199a-3p may be an early warning marker for acute rejection after liver transplantation in rats [J]. Cytokine, 2021, 148:155689. |
| 7 | 张继翔, 闫宏宪, 轩娟娟, 等. 门脉优先反向吻合快速建立肝移植大鼠模型[J]. 中国组织工程研究, 2022, 26(17): 2696-2701. |
| 8 | ZHOU M, HUI J, GAO L, et al. Extracellular vesicles from bone marrow mesenchymal stem cells alleviate acute rejection injury after liver transplantation by carrying miR-22-3p and inducing M2 polarization of Kupffer cells[J]. J Gene Med, 2023, e3497. |
| 9 | OLDANI G, PELOSO A, VIJGEN S, et al. Chimeric liver transplantation reveals interspecific graft remodelling[J]. J Hepatol, 2018, 69(5): 1025-1036. |
| 10 | SONG C, WANG G, MA X, et al. The effect of miR-155-5p on M1 polarization of Kupffer cells and immune response during liver transplantation through regulating the expression of KDM5D[J]. Mol Immunol, 2023, 155: 17-26. |
| 11 | MISUMI M, YAMAGUCHI Y, MORI K, et al. In situ macrophage distribution in the hepatic allograft associated with rejection in the rat[J]. J Surg Res, 1993, 55(2): 115-121. |
| 12 | GOMAA A I, EHSAN N A, ELREFAEI A A, et al. The role of monocyte/macrophage and CXCR3 in differentiation between recurrent hepatitis C and acute cellular rejection postliver transplantation[J]. J Immunol Res, 2018, 2018: 2726939. |
| 13 | SAWADA T, SHIMIZU A, KUBOTA K, et al. Lobular damage caused by cellular and humoral immunity in liver allograft rejection[J]. Clin Transplant, 2005, 19(1): 110-114. |
| 14 | ABDOU A G, ASAAD N Y, EHSAN N, et al. The diagnostic impact of C4d, CD68, and NF-κB expression in the differentiation between recurrent hepatitis C and acute cellular rejection after liver transplantation[J]. Appl Immunohistochem Mol Morphol, 2016, 24(9): 639-647. |
| 15 | 李泽桦, 曾宇宏, 冯丽芸, 等. 氧化三甲胺促进M1型巨噬细胞极化加剧心肌梗死后心室重构[J]. 实用医学杂志, 2022, 38(20): 2531-2537,2544. |
| 16 | CAO Z R, ZHENG W X, JIANG Y X, et al. miR-449a ameliorates acute rejection after liver transplantation via targeting procollagen-lysine1, 2-oxoglutarate5 -dioxygenase 1 in macrophages[J]. Am J Transplant, 2023, 23(3): 336-352. |
| 17 | YANG P, ZHANG X, LIN Z, et al. Adoptive transfer of polarized M2c macrophages ameliorates acute rejection in rat liver transplantation[J]. Am J Transl Res, 2020, 12(6): 2614-2626. |
| 18 | ANGERMüLLER S, STEINMETZ I, WEBER T, et al. Significant increase of Kuppfer cells associated with loss of Na+,K+-ATPase activity in rat hepatic allograft rejection[J]. Transplantation, 1997, 63(11):1562-1570. |
| 19 | LI X, LI S, WU B, et al. Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis[J]. Front Immunol, 2022, 13: 890019. |
| 20 | SU H, NA N, ZHANG X, et al. The biological function and significance of CD74 in immune diseases[J]. Inflamm Res, 2017, 66(3): 209-216. |
| 21 | XIAO N, LI K, ZHU X, et al. CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma[J]. Cancer Immunol Immunother, 2022, 71(1): 57-69. |
| 22 | YANG Z, HAN X, WANG K, et al. Combined with multiplex and network analysis to reveal the key genes and mechanisms of nonalcoholic fatty liver disease[J]. Int Immunopharmacol, 2023, 123: 110708. |
| 23 | MARCOVECCHIO P M, THOMAS G, SALEK-ARDAKANI S. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer[J]. J Immunother Cancer, 2021, 9(2): e002045. |
| 24 | MEHANNA R G, MOHIEDEEN K, KASSEM M, et al. Assessment of serum CXCL9 and pentraxin 3 as novel markers for hepatocellular carcinoma in cirrhotic hepatitis C patients[J]. Clin Exp Hepatol, 2023, 9(1):14-20. |
| 25 | ASAOKA T, MARUBASHI S, KOBAYASHI S, et al. Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation[J]. J Surg Res, 2012, 178(2): 1003-1014. |
| 26 | DENG J F, GENG L, QIAN Y G, et al. The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation[J]. Transplant Proc, 2007, 39(10): 3222-3224 |
/
| 〈 |
|
〉 |